colonic neoplasm: A benign or malignant neoplasm that affects the colon. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Colonic adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2369 |
4. Check minimum number of eventsNone |
2369 |
5. Include endpointsNone |
2369 |
6. Filter based on genotype QC (FinnGen only) |
2369 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D12
- Name in latin
- Neoplasma benignum coli descendentis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Descending colon
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Descending colon
- Benign neoplasm: Colon
- Benign neoplasm: Colon
- Benign neoplasm of colon, rectum, anus and anal canal
- Benign neoplasm of colon, rectum, anus and anal canal
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 11433 | 5068 | 6323 |
| Only index persons | 10736 | 4845 | 5891 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | 0.15 | 0.18 |
| Only index persons | 0.20 | 0.18 | 0.22 |
| Median age at first event (years) | |||
| Whole population | 67.11 | 67.05 | 67.17 |
| Only index persons | 66.90 | 66.85 | 66.95 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2369 | 1074 | 1295 |
| Unadjusted period prevalence (%) | 0.48 | 0.37 | 0.57 |
| Median age at first event (years) | 66.65 | 65.28 | 67.79 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2045
- Matched controls
- 20450
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
18.6
323.0
584
431
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
22.3
323.0
800
573
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
30.3
323.0
455
191
UJF32
NOMESCO Finland
Coloscopy
15.2
323.0
1586
3791
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
4503599627370496.0
323.0
2030
11
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
19.8
285.7
448
285
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
12.6
217.3
412
400
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
4.4
168.0
784
2556
UJF30
NOMESCO Finland
Ileoscopy through colon
6.0
164.7
516
1088
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
13.2
150.7
276
239
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
18.1
149.6
239
148
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
7.3
144.6
377
611
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.3
129.0
951
4295
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.7
103.2
396
999
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
54.4
796
4629
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
43.8
532
2784
JFA42
NOMESCO Finland
Endoscopic injection in colon
20.9
42.4
63
31
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
9.8
40.3
83
88
N02BE01
ATC
paracetamol; systemic, rectal
2.3
39.8
1796
15443
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
39.7
608
3494
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.2
39.5
229
783
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
39.2
1041
7323
A02BC02
ATC
pantoprazole; systemic
1.9
38.4
1407
11024
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
38.2
309
1303
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.9
38.0
253
949
B01AB05
ATC
enoxaparin; parenteral
1.9
37.8
742
4674
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
37.6
312
1335
K63.5
ICD-10 Finland
Polyp of colon
7.6
31.0
74
101
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
6.1
30.5
85
144
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
30.4
333
1627
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
6.8
28.5
73
111
WX002
NOMESCO Finland
Sedation and analgesia
1.9
28.3
483
2832
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.6
28.3
218
888
JN4BD
NOMESCO Finland
Extensive body CT
2.2
27.6
306
1501
P01AB01
ATC
metronidazole; oral, rectal
1.7
27.2
782
5426
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
27.1
284
1354
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
6.6
25.8
67
104
K92.1
ICD-10 Finland
Melaena
2.9
25.1
163
598
N02AX02
ATC
tramadol; systemic, rectal
1.6
24.9
901
6622
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
2.8
24.8
169
638
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
11.8
24.0
44
38
J01DB01
ATC
cefalexin; oral
1.7
23.1
1605
13897
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
4.0
23.0
93
238
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
22.3
377
2179
JFA55
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in colon
15.5
21.5
35
23
C07AB07
ATC
bisoprolol; oral
1.6
21.4
1062
8340
C10AA05
ATC
atorvastatin; oral
1.6
21.3
889
6685
S18
ICPC
Laceration/cut
1.6
21.1
899
6793
N03AX16
ATC
pregabalin; oral
1.7
21.0
499
3221
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
14.2
20.8
35
25
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
20.8
554
3692
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
20.6
580
3923
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.7
20.4
143
548
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
4.2
20.3
78
191
AA1AD
NOMESCO Finland
CT of head and brain
1.7
20.2
543
3626
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
20.0
554
3727
UJF34
NOMESCO Finland
Left colonoscopy
9.7
19.8
40
42
N06AX11
ATC
mirtazapine; oral
1.6
19.6
611
4243
L01BC06
ATC
capecitabine; oral
3.1
19.1
108
360
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
8.0
19.0
43
55
C03CA01
ATC
furosemide; systemic
1.6
18.9
664
4743
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
18.9
366
2208
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.2
18.8
102
332
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
4.8
18.7
62
131
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
18.5
234
1206
JFB30
NOMESCO Finland
Right hemicolectomy
5.0
18.4
59
120
WX110
NOMESCO Finland
Local anesthesy
1.5
18.2
1266
10560
K59.09
ICD-10 Finland
Constipation, unspecified
2.4
18.2
164
722
A10BA02
ATC
metformin; oral
1.6
18.1
624
4425
UJH02
NOMESCO Finland
Anoscopy
2.8
17.6
113
412
A02BC05
ATC
esomeprazole; systemic
1.5
17.5
797
6033
G47.3
ICD-10 Finland
Sleep apnoea
1.7
17.4
434
2819
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
5.7
17.2
49
87
JN4AD
NOMESCO Finland
Body CT examination
2.1
17.2
195
959
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
17.2
700
5154
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
9.8
16.7
33
34
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
27.8
16.5
22
8
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
16.4
590
4210
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
16.4
876
6836
D01
ICPC
Abdominal pain/cramps general
2.1
16.3
195
981
J01MA12
ATC
levofloxacin; systemic
1.7
16.3
400
2582
H02AB06
ATC
prednisolone; systemic
1.5
16.1
918
7248
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
16.1
357
2236
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
16.0
578
4120
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.6
15.7
120
486
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
15.6
1272
10787
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
16.2
15.2
24
15
JFB43
NOMESCO Finland
Left hemicolectomy
7.6
15.2
35
47
XKD00
NOMESCO Finland
Uroflowmetry
1.7
15.2
399
2617
C05AA08
ATC
fluocortolone; rectal, topical
1.8
15.1
304
1843
SPAT1104
SPAT
Monitoring of emergency patient
2.2
15.1
164
791
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
7.8
15.1
34
44
D11
ICPC
Diarrhoea
2.1
14.7
179
905
T90
ICPC
Diabetes non-insulin dependent
1.6
14.6
520
3685
A02BC03
ATC
lansoprazole; oral
1.5
14.6
588
4286
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
2.4
14.5
121
513
130
Kela drug reimbursment
Malignant tumour
2.0
14.5
202
1080
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.0
14.5
83
282
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
14.5
432
2929
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
6.5
14.4
37
58
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
14.2
734
5639
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.3
14.2
128
567
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
14.1
174
885
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
14.0
188
991
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
14.0
167
840
R03AC02
ATC
salbutamol; inhalant
1.4
13.9
938
7584
M54.5
ICD-10 Finland
Low back pain
1.5
13.8
583
4279
A08
ICPC
Swelling
2.6
13.7
104
419
A02BC01
ATC
omeprazole; systemic
1.5
13.7
560
4081
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
13.7
600
4440
A06AD11
ATC
lactulose; oral
1.7
13.6
321
2038
21135
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Coli descendentis
+∞
13.6
13
*
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
3.3
13.5
67
206
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
4.7
13.5
45
97
UJF92
NOMESCO Finland
Capsular endoscopy
3.8
13.5
57
154
D12.9
ICD-10 Finland
Benign neoplasm: Anus and anal canal
6.3
13.5
35
56
R51.80
ICD-10 Finland
Headache
1.8
13.5
236
1365
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
13.3
756
5897
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.7
13.3
90
339
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
13.3
224
1282
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
8.6
13.2
28
33
ZX120
NOMESCO Finland
Intravenous
1.9
13.1
199
1098
R4110
NOMESCO Finland
Physiotherapy
1.5
13.1
524
3795
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
13.0
356
2354
N03AX12
ATC
gabapentin; oral
1.7
12.8
302
1916
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
4.3
12.8
47
112
N05CF01
ATC
zopiclone; oral
1.5
12.8
630
4764
J01DA01
ATC
[U] cefalexin; systemic
1.4
12.6
1148
9739
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
12.6
881
7128
I84.5
ICD-10 Finland
External hemorrhoids without complication
2.8
12.4
78
284
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.0
12.3
165
869
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.6
12.3
89
352
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
12.2
270
1681
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.1
12.1
147
743
R06.0
ICD-10 Finland
Dyspnoea
1.5
12.0
505
3686
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.2
12.0
61
192
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
12.0
392
2705
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
12.0
322
2114
A10AE04
ATC
insulin glargine; parenteral
1.8
12.0
202
1155
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
12.0
184
1020
J01MA02
ATC
ciprofloxacin; systemic
1.4
11.9
765
6073
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
11.9
192
1082
JFB46
NOMESCO Finland
Resection of sigmoid colon
4.3
11.8
43
102
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
11.8
427
3011
C10AA01
ATC
simvastatin; oral
1.4
11.8
963
7969
E0000UV
ATC
NA
1.4
11.8
684
5322
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
8.4
11.8
25
30
ZXA00
NOMESCO Finland
Right side
1.5
11.8
557
4165
KMAK
NOMESCO Finland
NA
1.4
11.6
861
7006
SPAT1153
SPAT
Removal of sutures
1.4
11.5
660
5122
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.5
11.5
91
379
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
11.4
569
4292
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
11.4
230
1393
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
11.4
1206
10419
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
11.3
354
2413
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
11.3
648
5024
C08CA01
ATC
amlodipine; oral
1.4
11.2
772
6183
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
6.1
11.0
29
48
N05BA04
ATC
oxazepam; oral
1.5
11.0
433
3107
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.9
11.0
44
115
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
10.9
295
1939
A07EC02
ATC
mesalazine; oral, rectal
2.3
10.9
103
467
A02BA02
ATC
ranitidine; systemic
1.5
10.9
389
2736
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
10.8
221
1341
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
10.8
303
2010
R03BA02
ATC
budesonide; inhalant
1.6
10.8
300
1985
A98
ICPC
Health maint/preventive medicine
1.7
10.8
1868
17642
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
10.7
560
4254
SPAT1263
SPAT
Sampling
1.4
10.7
799
6479
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
10.6
482
3563
A10BB12
ATC
glimepiride; oral
1.8
10.6
171
963
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
10.6
650
5090
SPAT1254
SPAT
Administration of medicine
1.6
10.5
288
1897
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
10.5
255
1628
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.2
10.4
103
479
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
2.9
10.3
64
229
R53
ICD-10 Finland
Malaise and fatigue
1.5
10.3
357
2488
JFA52
NOMESCO Finland
Other endoscopic haemostatic procedure in colon
7.1
10.3
24
34
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
10.2
127
650
R4120
NOMESCO Finland
Occupational therapy
2.0
10.2
122
616
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
6.5
10.0
25
39
UJF02
NOMESCO Finland
Peroral enteroscopy
7.3
10.0
23
32
N06AX21
ATC
duloxetine; oral
1.8
10.0
178
1038
SPAT1301
SPAT
No procedures
1.4
10.0
617
4829
R02
ICPC
Shortness of breath/dyspnoea
1.7
9.9
235
1487
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.2
9.9
104
494
N06AX16
ATC
venlafaxine; oral
1.7
9.9
206
1257
J45.1
ICD-10 Finland
Nonallergic asthma
2.0
9.9
128
664
M04AA01
ATC
allopurinol; systemic
1.6
9.8
288
1931
SPAT1097
SPAT
Recording of ECG
1.5
9.8
312
2129
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
9.8
891
7427
A02BC04
ATC
rabeprazole; oral
1.9
9.8
153
854
UKC02
NOMESCO Finland
Cystoscopy
1.5
9.8
363
2569
M79.6
ICD-10 Finland
Pain in limb
1.4
9.7
638
5037
A10BH05
ATC
linagliptin; oral
2.1
9.7
114
570
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.9
9.7
57
200
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
5.1
9.7
29
57
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
9.7
272
1803
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.2
9.7
102
486
K29.7
ICD-10 Finland
Gastritis, unspecified
2.4
9.6
78
327
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
4.9
9.6
30
62
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
9.5
109
541
A10BH01
ATC
sitagliptin; oral
1.7
9.5
209
1295
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
3.2
9.5
47
147
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.1
9.4
99
475
JFB51
NOMESCO Finland
Other laparoscopic resection of colon
30.1
9.4
12
*
C18.50
ICD-10 Finland
Malignant tumor in flexural lienalis without histology
17.6
9.4
14
8
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
5.1
9.4
28
55
J01CA04
ATC
amoxicillin; systemic
1.4
9.3
1453
13133
JN4CD
NOMESCO Finland
Very extensive body CT
2.2
9.3
93
436
M03BX02
ATC
tizanidine; oral
1.3
9.3
1058
9109
E66.8
ICD-10 Finland
Other obesity
2.2
9.2
88
404
R01AD09
ATC
mometasone; nasal
1.4
9.2
726
5896
D06
ICPC
Abdominal pain localized other
1.9
9.2
139
767
R50.9
ICD-10 Finland
Fever, unspecified
1.6
9.1
243
1589
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.7
9.0
173
1029
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
5.6
9.0
25
45
K62.1
ICD-10 Finland
Rectal polyp
3.9
9.0
35
90
A07EA02
ATC
hydrocortisone; rectal
3.0
9.0
49
165
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
8.9
243
1599
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
8.8
456
3442
K59.1
ICD-10 Finland
Functional diarrhoea
2.1
8.8
97
475
N06AB04
ATC
citalopram; systemic
1.5
8.8
367
2658
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
8.8
310
2166
K55.2
ICD-10 Finland
Angiodysplasia of colon
5.4
8.7
25
47
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
6.0
8.7
23
39
N06AB10
ATC
escitalopram; oral
1.5
8.7
279
1906
J01FF01
ATC
clindamycin; systemic
1.4
8.7
478
3647
J01AA02
ATC
doxycycline; systemic
1.4
8.7
1475
13415
M48.0
ICD-10 Finland
Spinal stenosis
1.6
8.6
259
1743
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
8.6
796
6613
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
11.6
8.6
15
13
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.4
8.6
69
292
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
2.7
8.5
56
212
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
8.5
317
2239
R42
ICD-10 Finland
Dizziness and giddiness
1.4
8.5
414
3088
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
8.5
253
1698
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
8.5
283
1951
A01
ICPC
Pain general/multiple sites
1.8
8.4
140
800
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
8.4
268
1830
N05AH04
ATC
quetiapine; oral
1.6
8.4
242
1615
R60.0
ICD-10 Finland
Localized oedema
1.6
8.3
222
1448
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
8.3
316
2239
R03BB04
ATC
tiotropium bromide; inhalant
1.6
8.3
211
1363
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.1
8.3
88
424
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
8.3
359
2614
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
8.3
359
2616
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
8.3
1643
15253
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
8.3
114
611
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.2
8.2
81
378
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
8.2
113
601
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.9
8.1
115
621
B01AA03
ATC
warfarin; systemic
1.4
8.1
429
3242
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
8.1
227
1503
N05CF02
ATC
zolpidem; oral
1.5
8.1
284
1978
8140/3-C18.6
ICD-O-3
Adenocarcinoma, NOS, of descending colon
17.2
8.1
12
7
X58
ICD-10 Finland
Exposure to other specified factors
1.6
8.1
225
1485
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
2.2
8.0
81
382
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
8.0
302
2138
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.7
8.0
175
1088
B01AC04
ATC
clopidogrel; oral
1.5
8.0
342
2486
A46
ICD-10 Finland
Erysipelas
1.5
7.9
285
1997
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
7.9
324
2332
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.4
7.9
62
260
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
7.9
140
814
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
7.8
1041
9066
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
7.8
701
5770
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
6.1
7.8
20
33
Z71.8
ICD-10 Finland
Other specified counselling
1.4
7.8
379
2819
J01FA09
ATC
clarithromycin; systemic
1.4
7.8
499
3896
R19.4
ICD-10 Finland
Change in bowel habit
2.6
7.8
52
200
A04
ICPC
Weakness/tiredness general
1.6
7.8
219
1451
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
7.8
450
3458
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.8
7.8
130
742
K02.1
ICD-10 Finland
Caries of dentine
1.3
7.7
906
7745
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.6
7.7
54
213
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.4
7.7
63
269
D16
ICPC
Rectal bleeding
2.8
7.7
47
172
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
4.4
7.6
26
60
SPAT1262
SPAT
Handing over of treatment supplies
1.4
7.6
361
2671
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
7.6
489
3819
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
7.6
118
660
A03CA02
ATC
clidinium and psycholeptics; oral
1.8
7.6
118
660
TJX00
NOMESCO Finland
Punkture or biopsy in gastrointestinal endoscopy
25.1
7.6
10
*
L16
ICPC
Ankle symptom/complaint
1.7
7.5
164
1013
K30
ICD-10 Finland
Functional dyspepsia
1.6
7.5
174
1097
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
7.5
494
3875
K51.5
ICD-10 Finland
Left sided colitis
2.8
7.5
45
163
K59.0
ICD-10 Finland
Constipation
1.8
7.4
115
643
R01AD08
ATC
fluticasone; nasal
1.4
7.4
446
3443
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.6
7.4
212
1411
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
6.0
7.4
19
32
205
Kela drug reimbursment
Chronic hypertension
1.3
7.3
602
4885
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
4.7
7.3
23
49
D12.1
ICD-10 Finland
Benign neoplasm: Appendix
8.4
7.3
15
18
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
7.3
121
690
C03DA01
ATC
spironolactone; oral
1.6
7.3
211
1406
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
7.3
306
2214
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.2
7.3
69
317
K92.0
ICD-10 Finland
Haematemesis
2.5
7.3
52
208
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
6.8
7.3
17
25
K50.8
ICD-10 Finland
Other Crohn disease
3.9
7.3
28
73
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
7.2
551
4418
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
7.2
305
2205
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.6
7.2
180
1156
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
7.2
294
2112
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.6
7.2
189
1232
R4190
NOMESCO Finland
Nutritional therapy
2.4
7.2
58
248
R03DC03
ATC
montelukast; oral
1.5
7.1
241
1665
A07AA02
ATC
nystatin; oral
1.8
7.1
118
674
J02AC01
ATC
fluconazole; systemic
1.3
7.1
592
4807
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
7.1
750
6301
A06AC51
ATC
ispaghula, combinations; systemic
1.9
7.1
93
490
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.4
7.1
401
3060
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
7.1
197
1300
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.2
7.1
68
316
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
3.4
7.0
31
91
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.5
7.0
53
219
JHB00
NOMESCO Finland
Hemorrhoidectomy
2.2
7.0
65
298
A04.8
ICD-10 Finland
Other specified bacterial intestinal infections
3.1
7.0
35
113
K51.8
ICD-10 Finland
Other ulcerative colitis
3.7
7.0
28
76
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
6.9
916
7925
H02AB04
ATC
methylprednisolone; systemic
1.5
6.9
256
1808
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
6.9
561
4541
J01MA14
ATC
moxifloxacin; systemic
1.6
6.9
164
1045
K64.0
ICD-10 Finland
First degree haemorrhoids
3.2
6.9
34
109
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.0
6.8
86
445
D02AE01
ATC
carbamide; topical
1.8
6.8
120
697
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.8
6.8
111
631
D01AC02
ATC
miconazole; topical
1.7
6.8
149
928
SPAT1216
SPAT
Assessment of functional ability
1.4
6.8
303
2214
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
4.5
6.8
22
49
L17
ICPC
Foot/toe symptom/complaint
1.4
6.7
453
3555
D18
ICPC
Change in faeces/bowel movements
2.6
6.7
47
184
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.6
6.7
167
1075
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
2.4
6.7
52
219
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
3.6
6.7
28
79
K29.6
ICD-10 Finland
Other gastritis
3.2
6.6
32
101
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.9
6.6
87
461
N05CD07
ATC
temazepam; oral
1.5
6.6
229
1593
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.9
6.6
38
133
E66.00
ICD-10 Finland
Metabolic syndrome
1.9
6.6
98
539
Z97.4
ICD-10 Finland
Presence of external hearing-aid
1.8
6.6
100
555
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
6.6
203
1376
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.5
6.6
47
189
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
6.5
558
4537
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
6.5
915
7947
A07EA06
ATC
budesonide; oral, local oral
2.3
6.5
58
258
-60
ICPC
Result test/procedure
1.8
6.5
114
662
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
6.9
6.5
15
22
3AC01
NOMESCO Finland
NA
3.7
6.5
26
71
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.6
6.5
181
1197
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.0
6.5
75
378
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.9
6.4
93
507
D02
ICPC
Abdominal pain epigastric
1.9
6.4
93
507
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.8
6.4
110
636
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.7
6.4
117
691
A02BD07
ATC
lansoprazole, amoxicillin and clarithromycin; systemic
1.9
6.4
95
524
B82
ICPC
Anaemia other/unspecified
2.3
6.4
53
231
SPAT1101
SPAT
Orthostatic test
1.9
6.4
91
495
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.7
6.4
115
676
C07AA05
ATC
propranolol; systemic
1.4
6.4
290
2126
R31
ICD-10 Finland
Unspecified haematuria
1.5
6.4
209
1433
A11
ICPC
Chest pain NOS
1.6
6.4
148
937
JAH01
NOMESCO Finland
Laparoscopy
2.1
6.3
67
325
-1
NOMESCO Finland
NA
1.3
6.3
495
3976
N02AA05
ATC
oxycodone; systemic
1.4
6.3
285
2088
J01MA06
ATC
norfloxacin; oral
1.5
6.3
228
1598
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
6.3
94
520
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
6.3
124
747
M10.9
ICD-10 Finland
Gout, unspecified
1.6
6.3
142
889
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
6.3
179
1191
-
ICD-10 Finland
NA
2.3
6.3
52
227
R07.3
ICD-10 Finland
Other chest pain
1.6
6.3
173
1144
I78.8
ICD-10 Finland
Other diseases of capillaries
7.0
6.2
14
20
C10AC01
ATC
colestyramine; oral
2.3
6.2
51
221
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.1
6.2
62
295
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
6.2
127
777
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
6.2
249
1786
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
6.2
290
2138
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.9
6.2
85
457
JG1CG
NOMESCO Finland
Extensive MRI of rectum
4.5
6.2
20
45
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.7
6.1
109
639
R33
ICD-10 Finland
Retention of urine
1.6
6.1
161
1052
XF404
NOMESCO Finland
Ambulatory ECG
1.5
6.1
183
1229
WX892
NOMESCO Finland
Monitored bed care
1.6
6.1
145
922
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.0
6.1
78
407
N06AB06
ATC
sertraline; oral
1.6
6.1
151
972
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
6.0
207
1437
H25.8
ICD-10 Finland
Other senile cataract
1.5
6.0
225
1588
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.5
6.0
201
1384
J01FA10
ATC
azithromycin; systemic
1.3
6.0
902
7876
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
6.0
458
3661
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.4
6.0
46
191
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022145) Colonoscopy Study observation
918
2222
6.11
307.65
1.6
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
573
2418
2.81
91.07
5.3
4.1
ug/l
5.8
24.7
3.38
483
2001
(3024561) Albumin [Mass/volume] in Serum or Plasma
1424
9352
2.31
83.30
6.2
4.9
g/l
35.0
34.9
0.07
1360
8677
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1567
10989
2.26
74.32
7.3
6.4
umol/l
11.5
12.0
0.71
1498
10443
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
948
5456
2.23
73.96
2.8
2.2
mg/l
3.4
3.0
3.69
864
4617
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1985
15854
2.55
62.78
10.1
7.8
u/l
80.7
79.7
0.35
1914
14911
(3013707) Erythrocyte sedimentation rate by Westergren method
1881
14842
2.30
58.22
5.1
4.2
mm/h
14.9
13.4
3.30
1764
13655
(40768797) Stomach Pathology biopsy report
563
2895
2.24
55.24
1.3
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1179
7960
1.96
54.82
4.0
2.8
ug/l
134.6
154.2
2.19
1120
7255
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1288
8985
1.95
54.08
2.4
2.1
pmol/l
92.9
93.6
0.18
751
4684
(3048689) Calprotectin [Mass/mass] in Stool
430
1989
2.42
53.89
2.3
2.2
ug/g
149.5
157.2
0.17
346
1566
(3013650) Neutrophils [#/volume] in Blood by Automated count
1564
11680
2.00
53.43
10.1
9.0
e9/l
4.4
4.2
1.77
1392
10165
(3044640) Blood type and Crossmatch panel - Blood
1022
6638
1.95
52.64
3.0
2.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1470
10787
1.96
52.36
9.0
6.9
mmol/l
1.2
1.2
1.86
1362
9059
(3022948) Iron [Moles/volume] in Serum or Plasma
628
3439
2.12
52.15
3.6
2.5
umol/l
11.4
12.7
5.35
591
3191
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1007
6536
1.94
51.73
3.2
2.6
u/l
61.6
58.2
0.61
941
6017
(3004789) Transferrin [Mass/volume] in Serum or Plasma
591
3184
2.14
51.07
3.5
2.5
g/l
2.3
2.3
1.64
558
2957
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
565
3011
2.15
50.09
3.6
2.6
%
20.0
22.7
4.89
493
2579
(3006315) Basophils [#/volume] in Blood
1377
10013
1.90
48.94
6.8
5.7
e9/l
0.0
0.0
0.87
1209
8568
(40768804) Tissue Pathology biopsy report
1174
8121
1.88
48.69
2.6
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
829
5132
1.95
48.21
2.8
2.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1369
9966
1.89
48.15
6.8
5.7
e9/l
0.6
0.6
1.08
1205
8515
(3013115) Eosinophils [#/volume] in Blood
1404
10333
1.88
47.39
7.0
5.9
e9/l
0.2
0.2
0.20
1247
8971
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1356
9879
1.87
47.16
7.8
6.1
mmol/l
1.2
1.2
0.97
1275
8910
(3013826) Glucose [Moles/volume] in Serum or Plasma
1611
12452
1.92
46.01
6.2
5.0
mmol/l
7.0
6.8
1.74
1545
11755
(3019198) Lymphocytes [#/volume] in Blood
1384
10203
1.86
45.76
6.9
5.8
e9/l
1.9
1.9
0.16
1217
8885
(3031040) Bacteria [#/volume] in Urine by Automated count
1696
13371
1.94
45.13
5.8
4.7
e6/l
317.3
1754.3
—
6
218
(3032080) INR in Blood by Coagulation assay
1268
9205
1.81
42.97
11.6
10.4
inr
1.3
1.3
0.20
246
2561
(3019309) Folate [Moles/volume] in Red Blood Cells
711
4332
1.92
42.28
1.9
1.8
nmol/l
1109.7
1189.9
1.17
571
3234
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
625
3727
1.92
39.18
1.3
1.2
u/ml
2.3
1.4
0.37
164
964
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2199
19479
2.80
38.62
23.8
16.2
mg/l
26.1
26.1
0.04
1924
15721
(3037467) Urinalysis macro (dipstick) panel - Urine
1711
13827
1.85
38.40
5.6
4.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
403
2093
2.12
37.10
9.4
7.3
mmol/l
10.9
10.5
0.46
391
1990
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1285
9626
1.73
36.67
4.6
4.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
780
5124
1.78
35.11
7.6
6.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
794
5276
1.76
34.15
5.4
4.1
%
86.1
86.5
0.18
771
5154
(3007164) IgA [Mass/volume] in Serum or Plasma
560
3361
1.87
33.71
1.4
1.5
g/l
2.6
2.6
0.00
316
1988
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1139
8381
1.69
33.61
4.8
3.9
ng/l
39.2
110.1
0.78
873
6298
(3003458) Phosphate [Moles/volume] in Serum or Plasma
508
2962
1.91
33.40
7.7
5.7
mmol/l
1.0
1.0
0.17
484
2748
(3014576) Chloride [Moles/volume] in Serum or Plasma
500
2906
1.91
33.17
7.0
6.8
mmol/l
104.9
104.2
2.25
491
2830
(3011397) Hemoglobin [Presence] in Urine by Test strip
722
4719
1.76
32.59
5.2
3.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
331
1672
2.14
32.48
4.8
3.8
ng/l
107.0
93.6
1.49
304
1444
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
252
1152
2.33
31.52
2.7
2.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
982
7036
1.68
31.37
6.2
5.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1512
12138
1.68
30.77
4.3
3.2
u/l
61.9
55.0
1.39
1411
11129
(3018010) Neutrophils/100 leukocytes in Blood
1235
9440
1.64
30.23
7.2
5.9
%
59.1
58.0
2.27
1157
8792
(3019069) Monocytes/100 leukocytes in Blood
1232
9416
1.64
30.13
7.6
6.2
%
8.8
8.9
0.70
1163
8775
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
961
6926
1.65
29.48
3.6
3.1
ng/l
1690.8
1540.2
0.40
865
5982
(3023368) Bacteria identified in Blood by Culture
888
6275
1.66
29.41
4.9
4.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1223
9383
1.63
29.03
7.3
6.0
%
2.8
2.9
0.47
1157
8705
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1091
8142
1.63
28.95
2.6
2.2
nmol/l
77.7
78.7
0.53
1009
7152
(3015736) pH of Urine
1025
7539
1.63
28.80
5.0
3.5
—
5.8
—
0
6
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
585
3709
1.77
28.77
3.2
2.9
e6/l
1.0
1.2
0.76
352
2166
(3015377) Calcium [Moles/volume] in Serum or Plasma
991
7236
1.64
28.62
3.7
3.4
mmol/l
2.4
2.4
0.03
868
6250
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1741
14634
1.72
28.54
4.6
3.9
pmol/l
15.1
15.0
1.01
1614
13088
(3002030) Lymphocytes/100 leukocytes in Blood
1241
9591
1.62
28.31
7.4
6.1
%
25.7
26.7
2.50
1159
8885
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2259
20774
2.88
27.76
28.3
19.2
umol/l
86.8
81.5
5.81
2259
20768
(3022096) Basophils/100 leukocytes in Blood
1188
9137
1.60
27.24
7.2
6.0
%
0.7
0.7
0.76
1122
8493
(3026493) Urate [Moles/volume] in Serum or Plasma
809
5668
1.65
27.19
3.3
2.8
umol/l
3462.7
5551.2
0.90
711
4862
(3019550) Sodium [Moles/volume] in Serum or Plasma
2242
20590
2.66
26.70
28.6
19.1
mmol/l
139.7
139.7
0.19
2233
20068
(3027945) Reticulocytes/100 erythrocytes in Blood
451
2699
1.83
26.70
2.4
2.5
%
1.8
1.8
0.11
411
2376
(3002032) Base excess in Venous blood by calculation
377
2135
1.91
26.54
5.4
3.5
mmol/l
2.0
2.0
0.06
308
1706
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2016
17801
1.89
26.47
5.8
4.7
mu/l
2.0
2.1
0.09
1888
16019
(3021447) Carbon dioxide [Partial pressure] in Venous blood
377
2139
1.91
26.38
5.4
3.5
kpa
5.8
5.8
0.15
370
2075
(3020682) Albumin/Creatinine [Ratio] in Urine
964
7113
1.60
25.90
4.5
4.0
mg/mmol
10.9
8.8
0.67
686
4499
(3023103) Potassium [Moles/volume] in Serum or Plasma
2242
20636
2.61
25.72
28.8
19.3
mmol/l
4.0
4.0
1.46
2232
20094
(3009508) Creatinine [Moles/volume] in Urine
936
6887
1.59
25.28
3.7
3.2
mmol/l
7.4
7.4
0.12
823
5706
(3012516) Albumin [Mass/volume] in Urine
920
6747
1.59
25.16
3.8
3.3
mg/l
331.7
282.9
0.14
646
4284
(3000991) Gas panel - Venous blood
344
1927
1.92
24.93
8.0
8.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
445
2705
1.79
24.85
6.8
7.2
kpa
5.0
5.1
0.62
423
2576
(3022217) INR in Platelet poor plasma by Coagulation assay
499
3136
1.75
24.84
34.3
27.2
inr
1.5
1.4
0.72
46
438
(3027801) Oxygen [Partial pressure] in Arterial blood
445
2706
1.79
24.81
6.8
7.2
kpa
12.1
12.0
0.19
420
2579
(3003396) Base excess in Arterial blood by calculation
445
2708
1.79
24.75
7.0
7.2
mmol/l
0.9
1.1
0.37
338
2114
(40761511) CBC panel - Blood by Automated count
2192
20032
2.26
24.65
22.5
15.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
905
6647
1.58
24.39
2.3
2.2
u/l
212.0
230.4
0.20
867
6221
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
394
2332
1.83
23.96
2.9
2.8
umol/l
8.8
8.7
0.01
348
2056
(3030467) Casts [#/volume] in Urine by Automated count
827
5967
1.59
23.93
3.9
3.3
e6/l
0.5
0.5
0.28
632
4570
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
220
1067
2.17
23.67
3.8
2.5
%
1.3
1.1
1.45
220
1057
(3021960) Folate [Moles/volume] in Serum or Plasma
751
5312
1.61
23.55
1.7
1.6
nmol/l
20.1
20.4
0.19
672
4470
(3009261) Glucose [Presence] in Urine by Test strip
1240
9830
1.55
23.54
5.2
3.8
estimate
0.0
0.0
0.80
150
1789
(3019150) Specific gravity of Urine by Refractometry
633
4294
1.65
23.52
5.8
4.2
kg/l
1.0
1.0
0.07
113
640
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
362
2101
1.85
23.41
2.8
2.1
g/l
0.2
0.2
0.74
344
1951
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2243
20769
2.50
23.22
15.3
11.2
u/l
25.9
26.0
0.10
2204
19958
(3018095) Leukocytes [#/volume] in Urine
986
7453
1.55
23.05
4.6
3.8
e6/l
69.0
115.7
1.50
719
5448
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
337
1922
1.88
23.00
2.8
2.4
u/l
34.1
38.9
0.68
286
1648
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
292
1590
1.95
22.92
1.8
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2068
18624
1.87
22.52
8.3
6.4
mmol/mol
41.4
40.6
3.79
1959
17022
(3024354) Oxygen [Partial pressure] in Venous blood
312
1748
1.90
22.47
4.4
2.9
kpa
4.4
4.5
0.41
305
1691
(3016502) Oxygen saturation in Arterial blood
402
2446
1.78
22.16
7.1
7.5
%
95.5
95.5
0.03
389
2350
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
606
4122
1.63
22.05
3.7
3.1
mmol/l
2.5
2.5
1.15
529
3634
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
212
1043
2.13
21.96
3.5
2.4
%
0.7
0.6
0.27
205
993
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
527
3465
1.67
21.89
3.5
3.1
e6/l
2.4
2.0
0.42
300
1932
(36304419) Bacteria [Presence] in Urine
790
5754
1.56
21.39
3.9
3.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1213
9692
1.52
21.35
5.1
3.8
estimate
0.0
0.0
0.00
150
1830
(3002582) Erythrocytes [#/volume] in Urine
874
6526
1.54
21.07
4.0
3.4
e6/l
66.2
91.5
0.29
678
5099
(3026008) Bacteria identified in Urine by Culture
862
6437
1.53
20.67
3.8
3.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
321
1862
1.84
20.65
4.5
3.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
220
1124
2.06
20.60
1.6
1.7
g/l
1.5
1.5
0.06
195
964
(3014007) Fractional oxyhemoglobin in Arterial blood
271
1492
1.92
20.50
7.4
9.0
%
93.7
93.9
0.16
271
1484
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
212
1075
2.07
20.25
5.5
3.7
mmol/l
24.3
24.1
0.36
190
952
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
845
6307
1.53
20.19
3.6
3.2
u/l
39.3
40.4
0.06
792
5994
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2155
19815
1.97
19.91
6.3
5.4
mmol/l
2.5
2.7
8.73
2035
17994
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
133
560
2.46
19.89
1.3
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
343
2056
1.78
19.74
2.4
2.5
e9/l
71.2
69.5
0.41
280
1572
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2116
19352
1.87
19.72
6.1
5.0
mmol/l
6.2
6.1
7.40
1999
17405
(3021601) Nitrite [Presence] in Urine by Test strip
1205
9715
1.49
19.64
6.9
5.1
estimate
0.0
0.0
0.00
157
1861
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2052
18607
1.77
19.52
20.8
15.3
ml/min/173m2
74.3
76.0
2.80
1783
15433
(3014765) Yersinia sp identified in Stool by Organism specific culture
133
565
2.43
19.51
1.3
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
339
2033
1.78
19.46
6.2
7.0
mmol/l
1.4
1.4
0.31
326
1964
(3007461) Platelets [#/volume] in Blood
2271
21333
2.56
19.43
36.7
23.9
e9/l
244.8
243.6
0.40
2254
20743
(3002173) Hemoglobin [Mass/volume] in Arterial blood
365
2238
1.75
19.40
7.7
8.0
g/l
117.9
121.3
2.44
352
2156
(3000570) Elastase.pancreatic [Mass/mass] in Stool
141
617
2.37
19.36
1.5
1.4
ug/g
235.7
271.3
1.46
98
367
(3035941) MCH [Entitic mass]
2271
21338
2.55
19.33
36.5
23.7
pg
30.4
30.5
1.85
2262
20979
(3024731) MCV [Entitic volume]
2271
21338
2.55
19.33
36.5
23.8
fl
91.7
91.6
0.38
2263
20981
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
324
1921
1.80
19.33
2.1
1.8
%
1.6
1.6
0.57
280
1627
(3026361) Erythrocytes [#/volume] in Blood
2271
21340
2.55
19.29
36.7
23.8
e12/l
4.4
4.4
9.38
2252
20676
(3010813) Leukocytes [#/volume] in Blood
2271
21342
2.55
19.25
36.7
23.9
e9/l
7.0
6.8
5.64
2251
20678
(3000963) Hemoglobin [Mass/volume] in Blood
2271
21343
2.55
19.23
36.9
24.0
g/l
131.6
134.6
15.66
2263
20987
(42529406) Shigella sp [Presence] in Stool by Culture
133
570
2.41
19.13
1.3
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
610
4292
1.57
18.79
2.1
1.8
mg/l
1.2
1.4
0.61
502
3359
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2046
18584
1.74
18.74
5.0
4.2
mmol/l
1.4
1.3
6.85
1923
16699
(3012095) Magnesium [Moles/volume] in Serum or Plasma
528
3599
1.60
18.61
3.7
3.2
mmol/l
0.8
0.8
0.46
493
3368
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
342
2089
1.74
18.36
2.8
2.5
ug/l
6.7
7.4
0.18
298
1837
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
295
1758
1.77
17.20
2.9
2.8
ml/min/173m2
60.2
62.3
0.39
132
722
(3006462) Nitrate [Presence] in Urine
41
92
4.52
17.06
5.6
3.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
378
2418
1.67
17.05
1.3
1.3
titre
533.3
519.6
0.06
93
540
(3026782) Osmolality of Urine
595
4268
1.53
16.46
3.4
2.8
mosm/kgh2o
561.1
551.9
0.41
504
3633
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
405
2659
1.63
16.45
3.9
4.3
u/l
233.5
247.6
1.32
384
2504
(36660697) Celiac disease serology panel - Serum
233
1314
1.86
16.26
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
834
6419
1.46
16.25
5.7
4.1
ph
7.4
7.4
1.47
89
1244
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2084
19198
1.71
15.93
5.4
4.7
mmol/l
1.4
1.4
7.74
1971
17402
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2097
19353
1.73
15.89
5.6
4.8
mmol/l
4.4
4.5
9.23
1987
17683
(4211845)
42
102
4.17
15.83
5.5
3.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
626
4588
1.50
15.48
2.9
2.7
e6/l
4.2
5.0
0.59
525
4045
(3013512) EKG study
842
6549
1.44
15.29
5.0
4.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
370
2416
1.63
15.28
2.0
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
448
3063
1.57
15.25
2.3
2.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
266
1596
1.75
15.08
5.8
4.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
117
527
2.28
15.06
2.0
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
193
1058
1.90
14.69
3.8
3.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
522
3721
1.52
14.64
2.0
1.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
77
289
2.72
14.61
3.1
2.3
u/ml
5.6
204.3
0.78
77
281
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
158
814
2.01
14.42
2.4
2.3
ug/l
473.0
784.3
0.54
146
769
(3020630) Protein [Mass/volume] in Serum or Plasma
310
1981
1.65
13.88
2.4
2.7
g/l
65.6
66.4
1.10
276
1811
(3004716) Salmonella sp identified in Stool by Organism specific culture
151
782
1.99
13.59
1.4
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
407
2790
1.55
13.56
12.1
7.4
—
—
—
0
0
(3020891) Body temperature
173
940
1.91
13.53
5.8
4.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
486
3465
1.51
13.49
2.1
2.0
s
30.3
30.0
0.38
472
3359
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
162
862
1.94
13.48
3.7
3.3
u/ml
186.0
5690.1
1.01
138
733
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1198
10071
1.38
13.28
2.6
2.4
—
—
—
0
0
(3044889) 12 lead EKG panel
1638
14510
1.42
13.27
4.9
4.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
441
3102
1.52
13.01
1.3
1.2
iu/ml
24.9
38.1
2.76
134
976
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
580
4320
1.45
12.84
4.6
4.0
ng/l
222.6
628.7
1.22
483
3622
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
156
834
1.93
12.81
2.8
3.0
u/ml
0.3
0.3
1.17
87
475
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
240
1469
1.71
12.62
4.0
3.8
kpa
5.1
5.2
0.22
220
1360
(3000494) Fungus identified in Specimen by Culture
359
2429
1.56
12.62
1.6
1.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
155
836
1.91
12.40
4.8
3.7
mmol/l
1.3
1.4
0.47
150
822
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
423
2977
1.51
12.40
1.3
1.2
u/ml
16.8
12.4
0.40
154
1101
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
229
1391
1.72
12.38
4.0
3.7
mmol/l
1.6
1.9
0.67
167
1037
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
56
196
2.90
12.14
1.3
1.2
u/l
58.7
58.7
0.00
38
139
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
212
1272
1.73
11.97
7.2
9.4
mmol/l
24.0
24.4
1.10
196
1191
(3009343) pH of Capillary blood
235
1451
1.69
11.95
4.0
3.8
ph
7.4
7.4
0.53
21
185
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
160
887
1.86
11.77
4.0
4.1
mmol/l
24.7
24.9
0.35
144
823
(3025941) Bacteria identified in Stool by Culture
175
1001
1.81
11.64
1.3
1.3
—
—
—
0
0
(3019225) pH of Specimen
331
2242
1.55
11.52
4.6
4.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1862
17032
1.44
11.42
25.9
17.6
%
37.7
39.2
6.27
1238
11093
(3017143) Hepatitis C virus Ab [Presence] in Serum
263
1697
1.62
11.25
1.9
1.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
234
1468
1.66
11.19
9.2
6.7
mmol/l
24.3
24.5
0.44
221
1369
(3003338) MCHC [Mass/volume]
1732
15689
1.39
10.87
33.3
21.4
g/l
330.0
332.0
15.08
1725
15563
(3004588) Protein electrophoresis panel - Serum or Plasma
258
1672
1.61
10.83
2.3
2.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
68
282
2.45
10.62
1.5
1.6
g/l
0.7
0.9
1.00
59
212
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
228
1440
1.65
10.62
1.9
1.7
—
—
—
0
0
(4010399)
233
1485
1.63
10.47
1.4
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
211
1312
1.67
10.44
1.5
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
58
226
2.61
10.31
2.7
2.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
112
580
1.98
10.13
1.5
1.5
—
—
—
0
0
(4035726)
284
1921
1.54
9.89
1.5
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
131
724
1.86
9.76
1.4
1.5
titre
88.0
195.3
—
5
30
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
138
783
1.81
9.46
1.1
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
265
1784
1.55
9.42
1.8
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
100
512
2.00
9.36
3.5
3.3
u/ml
73.6
876.7
0.96
92
477
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
360
2586
1.46
9.36
1.8
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
119
649
1.88
9.26
1.8
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
200
1271
1.63
9.09
1.2
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
170
1045
1.68
8.80
5.9
3.8
%
50.2
47.9
0.62
170
1032
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
357
2592
1.44
8.74
1.8
1.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
29
84
3.48
8.64
2.6
2.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
93
478
1.98
8.64
4.0
2.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
667
5378
1.33
8.63
5.6
4.1
estimate
0.0
0.0
0.69
154
1749
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
120
672
1.83
8.60
1.3
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
225
1490
1.56
8.60
2.6
2.8
g/l
10.4
10.7
0.42
213
1355
(3052851) Hemolysis interference index of Serum or Plasma
115
636
1.85
8.58
3.9
3.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
262
1797
1.51
8.54
2.7
2.2
nmol/l
369.7
368.6
0.03
239
1630
(3021589) Normoblasts [#/volume] in Blood
1026
8787
1.30
8.53
11.7
10.1
e9/l
0.0
0.0
0.33
853
7171
(3000492) Spirometry study
250
1699
1.53
8.50
1.5
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
196
1260
1.61
8.50
2.6
2.5
au/ml
29.9
22.8
—
6
44
(46235355) HIV 1 and 2 tests - Meaningful Use set
296
2088
1.48
8.41
1.9
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
99
526
1.92
8.36
1.5
1.4
g/l
0.2
0.2
0.06
93
501
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
179
1133
1.63
8.27
1.4
1.3
au/ml
28.3
52.8
—
9
49
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
153
931
1.69
8.24
2.2
2.5
g/l
3.9
3.8
0.31
98
682
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
153
932
1.69
8.21
2.2
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
153
933
1.68
8.17
2.2
2.5
g/l
7.9
7.4
1.70
102
714
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
588
4696
1.34
8.03
1.7
1.7
pmol/l
39689159.0
25515155.1
0.26
514
3837
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
880
7435
1.29
7.96
5.7
4.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
144
877
1.68
7.74
2.1
2.5
g/l
10.0
10.4
0.52
114
752
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
57
253
2.28
7.74
1.7
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
32
106
3.05
7.74
1.8
1.4
u/field
4.0
2.4
0.41
20
80
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
69
332
2.11
7.69
1.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
143
872
1.68
7.65
2.1
1.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
158
994
1.63
7.50
2.0
1.9
ug/l
1.6
2.4
0.72
143
876
(3002256) Pathology report gross observation
365
2734
1.40
7.45
1.4
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
40
154
2.62
7.37
1.5
1.2
nmol/l
327.7
365.4
0.56
35
128
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
193
1279
1.55
7.36
9.4
9.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
90
486
1.89
7.28
3.3
2.8
umol/l
32.7
37.5
0.80
71
409
(3028192) IgG subclass 2 [Mass/volume] in Serum
43
173
2.51
7.26
1.3
1.4
g/l
2.8
3.0
0.28
34
119
(3024139) IgG subclass 3 [Mass/volume] in Serum
43
173
2.51
7.26
1.3
1.4
g/l
0.5
0.4
0.39
33
119
(3027135) IgG subclass 1 [Mass/volume] in Serum
43
173
2.51
7.26
1.3
1.4
g/l
7.4
7.1
0.20
34
118
(3028026) IgM [Mass/volume] in Serum or Plasma
180
1179
1.57
7.23
1.9
1.8
g/l
1.5
1.5
0.09
164
1075
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
29
95
3.08
7.16
2.2
2.5
u/ml
704.0
1411.6
1.53
29
95
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
61
288
2.15
7.16
3.2
2.4
mg/l
34.4
22.8
0.56
15
67
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
150
947
1.62
7.03
2.2
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
497
6152
0.76
6.90
3.2
3.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
131
804
1.67
6.87
2.5
2.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
87
474
1.87
6.87
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
87
474
1.87
6.87
1.4
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1000
8698
1.26
6.83
5.6
5.2
ug/l
2.9
3.6
0.38
905
7732
(3037121) Protein [Mass/volume] in Urine
125
759
1.68
6.83
3.6
3.1
g/l
0.5
0.3
0.77
61
304
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
83
447
1.89
6.79
1.4
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
62
302
2.08
6.74
1.6
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
298
2198
1.41
6.63
1.3
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
91
511
1.81
6.54
1.3
1.2
titre
171.2
95.1
—
8
35
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
125
768
1.66
6.54
2.7
3.5
ratio
1.3
1.7
0.59
12
55
(3034860) Kappa light chains.free [Mass/volume] in Serum
128
792
1.65
6.52
2.7
3.5
mg/l
54.9
57.2
0.08
115
648
(3038177) Helicobacter pylori Ab [Presence] in Serum
52
240
2.19
6.49
1.3
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
55
260
2.14
6.47
1.5
2.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
79
428
1.87
6.37
1.1
1.2
—
348.9
—
0
9
(3037756) Immunofixation for Serum or Plasma
91
517
1.79
6.31
1.4
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
137
870
1.61
6.30
2.1
2.5
g/l
3.3
3.1
0.72
100
698
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
127
793
1.64
6.25
2.7
3.5
mg/l
36.6
74.5
1.34
112
651
(3027456) Digoxin [Moles/volume] in Serum or Plasma
92
528
1.77
6.17
3.3
3.2
nmol/l
0.8
0.8
0.66
76
408
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
354
2717
1.36
6.17
4.5
4.8
%
33.0
32.9
0.06
272
1751
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
99
584
1.73
6.04
2.6
2.3
ug/min
196.6
91.2
1.16
61
351
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
22
68
3.26
6.00
2.5
2.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
45
203
2.24
5.96
1.1
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
118
738
1.63
5.79
2.1
2.3
g/l
36.2
37.5
1.21
94
641
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
126
803
1.60
5.73
2.1
2.6
g/l
0.6
1.3
1.89
102
702
(3025468) Yersinia sp identified in Specimen by Organism specific culture
54
268
2.04
5.64
1.8
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
54
268
2.04
5.64
1.7
1.5
—
—
—
0
0
(4062490)
40
176
2.29
5.63
1.3
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
18
51
3.55
5.60
8.2
4.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
54
269
2.03
5.59
1.7
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
54
270
2.02
5.53
1.7
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
70
384
1.85
5.48
7.0
5.3
iu/ml
195.8
763.0
0.85
13
52
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
112
702
1.62
5.47
2.1
2.4
g/l
0.0
0.0
0.08
97
651
(3033705) Calcium.ionized [Moles/volume] in Venous blood
55
279
1.99
5.42
3.2
2.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
54
273
2.00
5.38
1.7
1.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
56
287
1.97
5.37
3.1
2.5
mmol/l
4.1
4.1
0.05
56
282
(3035285) Chloride [Moles/volume] in Venous blood
56
287
1.97
5.37
3.1
2.5
mmol/l
106.3
105.4
0.85
56
282
(3015171) Extractable nuclear Ab [Units/volume] in Serum
106
660
1.63
5.32
1.3
1.2
u/ml
1.6
0.7
—
8
59
(40768443) Skin Pathology biopsy report
137
908
1.54
5.29
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
45
214
2.12
5.27
4.1
3.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
80
463
1.75
5.26
1.6
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
160
1101
1.49
5.18
1.6
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
188
1340
1.44
5.08
2.8
3.3
e9/l
4.7
4.3
0.72
136
995
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
105
661
1.62
5.06
2.2
2.4
g/l
0.0
0.0
0.00
90
617
(40761536) Microorganisms panel - Urine sediment
113
1715
0.64
5.06
5.8
4.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
75
433
1.76
4.99
1.7
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
28
111
2.54
4.96
1.2
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
95
587
1.64
4.94
2.4
2.4
g/l
3.8
3.6
0.61
90
552
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
15
41
3.68
4.92
1.1
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
105
666
1.60
4.92
2.2
2.4
g/l
0.0
0.0
0.00
90
618
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
56
297
1.91
4.89
1.7
1.4
u/ml
119.8
123.2
0.08
11
54
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
34
149
2.30
4.87
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
74
430
1.74
4.83
2.8
1.5
nmol/l
0.8
0.8
0.10
59
351
(3000475) Leukocytes [#/volume] in Synovial fluid
88
539
1.66
4.75
1.8
1.7
e6/l
12492.3
15045.9
0.22
59
388
(3020491) Glucose [Moles/volume] in Blood
34
152
2.25
4.66
1.6
2.2
mmol/l
6.9
7.2
0.44
20
96
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
87
535
1.65
4.63
4.1
2.8
mg/l
1.8
1.7
0.54
76
484
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
15
43
3.50
4.61
1.1
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
90
560
1.63
4.58
1.5
1.6
iu/ml
27.9
12.0
0.22
26
114
(3005322) IgE [Units/volume] in Serum or Plasma
146
1018
1.46
4.46
1.3
1.3
u/ml
111.2
208.6
3.77
134
932
(3011985) Renin [Units/volume] in Plasma
50
264
1.91
4.46
1.3
1.4
mu/l
175.9
59.3
0.78
42
231
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
797
7000
1.21
4.43
4.7
4.5
%
22.0
21.8
0.19
432
3602
(3024522) Salmonella sp identified in Specimen by Organism specific culture
51
272
1.89
4.41
1.8
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
32
143
2.25
4.41
1.3
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
35
163
2.16
4.37
1.4
1.4
u/l
11.5
13.7
1.40
35
154
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
38
183
2.09
4.37
2.0
2.1
u/field
3.4
2.3
0.20
19
66
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
70
413
1.72
4.36
1.1
1.1
u/ml
0.9
5.5
—
6
38
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
264
2055
1.32
4.17
3.3
3.1
ng/l
228.8
215.6
0.23
245
1881
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
93
601
1.57
4.08
1.6
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
93
602
1.57
4.05
2.0
2.2
%
90.9
88.9
0.30
86
578
(3051651) Icteric interference index of Serum or Plasma
28
123
2.29
4.03
3.8
3.7
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
32
149
2.16
4.02
1.1
1.2
titre
134.0
117.8
—
5
27
(3049717) Cytology report of Urine Cyto stain
140
989
1.44
4.02
3.0
2.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
488
4123
1.23
3.94
5.7
4.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
45
240
1.89
3.93
1.3
1.4
pmol/l
397.3
275.6
0.78
37
182
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
27
119
2.28
3.87
1.7
1.6
u/l
6.5
7.9
0.19
15
60
(3045414) Leukocytes [Presence] in Urine
132
931
1.44
3.84
2.1
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
59
346
1.72
3.80
1.2
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
59
346
1.72
3.80
1.7
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
244
1907
1.31
3.76
1.6
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
91
598
1.54
3.74
2.4
3.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
62
1002
0.61
3.71
1.5
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
26
115
2.27
3.71
6.1
16.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
46
253
1.83
3.68
1.7
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
58
342
1.71
3.67
1.4
1.2
u/ml
11.6
53.0
—
7
33
(3030981) Hyaline casts [#/volume] in Urine by Automated count
160
1179
1.38
3.64
2.7
2.8
e6/l
0.1
0.3
1.60
154
1157
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
11
30
3.68
3.64
1.0
1.8
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
21
85
2.48
3.63
6.9
7.4
mg/l
53.1
63.9
0.82
15
64
(3023487) Leukocytes [#/volume] in Peritoneal fluid
21
85
2.48
3.63
4.1
2.3
e6/l
776.3
746.5
0.03
14
70
(3002385) Erythrocyte distribution width [Ratio]
1659
15712
1.19
3.54
29.3
19.8
%
14.2
13.8
14.91
1642
15348
(3036489) Thrombin time
108
748
1.47
3.48
1.9
2.0
s
23.0
21.7
0.50
93
679
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
19
75
2.55
3.46
3.9
2.2
e6/l
933.8
25107.4
0.56
11
47
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
26
119
2.20
3.44
1.8
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
26
119
2.20
3.44
1.8
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
51
296
1.74
3.44
1.3
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
64
396
1.63
3.41
1.4
1.2
u/ml
1.9
5.3
—
5
27
(3021788) Differential panel - Synovial fluid
64
396
1.63
3.41
1.6
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
57
343
1.68
3.38
1.4
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
74
476
1.57
3.37
1.4
1.2
u/ml
1.6
8.3
—
10
74
(3007930) Methemoglobin/Hemoglobin.total in Blood
130
940
1.41
3.33
7.4
5.2
%
0.9
0.9
1.18
121
878
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
42
233
1.82
3.30
1.5
1.3
nmol/l
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
19
4.75
3.23
1.1
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
80
530
1.53
3.21
1.2
1.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
19
78
2.45
3.21
1.3
1.4
mmol/l
4.0
3.2
0.22
19
68
(3033799) Differential panel - Peritoneal fluid
18
72
2.51
3.21
2.7
1.9
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
51
304
1.69
3.15
3.0
2.6
—
2494.8
—
0
23
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
85
2.36
3.15
1.2
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
45
259
1.75
3.15
1.3
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
84
566
1.50
3.13
1.8
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
130
952
1.39
3.11
6.7
5.1
%
1.8
1.6
0.98
122
887
(3011648) Oxygen content in Venous blood
33
173
1.92
3.09
2.6
1.8
%
10.4
10.9
0.30
33
173
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
43
246
1.76
3.08
1.4
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
117
844
1.41
3.06
1.9
1.8
u/l
37.9
38.6
0.14
103
730
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
30
153
1.97
3.04
1.5
1.4
u/l
30.7
33.3
0.14
24
120
(3024891) Influenza virus A+B Ag [Presence] in Specimen
69
451
1.55
2.97
1.2
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
39
220
1.79
2.94
1.5
1.2
u/ml
158.8
63.6
—
5
9
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
35
191
1.84
2.93
2.0
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
35
191
1.84
2.93
2.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
35
191
1.84
2.93
2.0
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
34
184
1.86
2.92
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
569
5007
1.18
2.92
3.3
3.2
ug/l
0.8
0.8
0.17
430
3487
(3020876) Protein [Mass/time] in 24 hour Urine
37
206
1.81
2.91
1.7
2.0
g/24h
1.0
1.6
—
5
7
(3048879) Bone marrow aspiration report
17
70
2.44
2.88
1.7
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
71
471
1.52
2.87
1.4
1.2
u/ml
1.5
3.7
—
7
46
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
30
157
1.92
2.85
1.2
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
37
209
1.78
2.79
1.5
2.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
31
166
1.88
2.76
1.4
1.5
u/ml
34.4
23.9
—
5
32
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
34
189
1.81
2.71
1.1
1.0
u/ml
2.9
2.2
—
10
65
(3022689) Creatine [Moles/volume] in Urine
14
54
2.60
2.70
1.9
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
30
161
1.87
2.66
2.3
2.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
26
481
0.54
2.65
6.1
3.7
mg/l
32.5
28.7
0.13
15
295
(3023419) Bacteria identified in Sputum by Culture
50
312
1.62
2.65
2.8
2.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
107
782
1.39
2.64
2.0
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
80
555
1.46
2.63
2.0
2.4
%
221.1
197.6
1.66
72
531
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
141
1077
1.33
2.63
2.9
3.2
pmol/l
4.2
4.4
0.90
130
932
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
43
259
1.67
2.61
1.1
1.2
u/ml
2.5
5.5
1.44
17
113
(3034274) Bile acid [Moles/volume] in Serum --fasting
18
80
2.26
2.60
1.5
1.2
umol/l
8.0
16.9
0.46
13
44
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
25
127
1.98
2.60
2.0
1.5
g/l
1.0
1.0
0.13
25
127
(3019832) Treponema pallidum Ab [Presence] in Serum
90
641
1.42
2.58
1.5
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
74
508
1.47
2.57
2.9
2.2
g/l
126.8
128.6
0.18
44
375
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
8
20
4.01
2.56
2.0
2.4
u/field
1.1
0.7
—
8
20
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
97
701
1.40
2.56
2.0
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
38
223
1.72
2.54
2.0
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
48
300
1.61
2.54
1.2
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
14
56
2.51
2.53
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
18
82
2.20
2.47
1.2
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
31
173
1.80
2.46
1.2
1.3
—
30.6
—
0
10
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
253
2098
1.23
2.45
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
83
590
1.42
2.42
6.5
4.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
31
174
1.79
2.42
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
27
145
1.87
2.42
1.1
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
61
409
1.50
2.40
1.5
1.3
mmol/l
72.0
61.0
1.19
46
327
(1001926) Buprenorphine [Presence] in Urine by Screen method
31
175
1.78
2.38
2.5
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
66
451
1.48
2.37
3.7
2.9
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
8
6.26
2.37
1.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
38
228
1.68
2.37
2.5
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
22
111
1.99
2.35
3.0
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
47
299
1.58
2.34
1.3
1.2
u/ml
326.5
282.2
0.36
37
178
(3028300) Cannabinoids [Presence] in Urine
38
229
1.67
2.33
2.6
1.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
26
140
1.87
2.32
1.0
1.3
—
73.1
—
0
13
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
50
324
1.55
2.30
1.2
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
14
59
2.38
2.29
1.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
36
215
1.68
2.29
2.6
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
21
106
1.99
2.25
1.0
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
42
263
1.61
2.24
1.8
1.6
%
54.3
63.6
0.68
27
165
(3003694) ABO and Rh group [Type] in Blood
566
5075
1.15
2.23
1.3
1.3
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
16
73
2.20
2.21
1.3
1.2
g/l
33.1
39.7
—
8
40
(44806118)
38
234
1.63
2.17
1.5
1.5
—
—
—
0
0
(44790048)
38
234
1.63
2.17
1.5
1.5
—
—
—
0
0
(44790049)
38
234
1.63
2.17
1.5
1.5
—
—
—
0
0
(44790047)
38
234
1.63
2.17
1.5
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
62
427
1.46
2.17
1.2
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
72
511
1.42
2.15
5.6
3.2
mmol/l
1.7
1.6
0.68
72
499
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
19
3.69
2.15
9.9
4.6
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
19
3.69
2.15
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
37
227
1.64
2.15
2.5
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
40
251
1.60
2.13
1.3
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
13
55
2.37
2.12
1.5
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
74
530
1.41
2.11
3.6
3.0
kpa
7.7
7.9
0.50
68
483
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
116
1.90
2.11
2.1
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32
190
1.69
2.10
1.3
1.3
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
68
481
1.43
2.08
5.9
3.3
mmol/l
8.2
7.6
0.91
68
470
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
130
1020
1.29
2.05
1.1
1.2
iu/ml
108.9
138.4
0.44
50
362
(3028717) Thiamine [Mass/volume] in Blood
7
20
3.51
2.05
1.4
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
55
375
1.48
2.04
1.5
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
34
208
1.64
2.01
1.9
1.4
e6/l
6737.6
114439.2
1.43
25
140
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
86
638
1.36
2.01
2.0
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
14
63
2.23
2.01
1.4
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
20
104
1.93
2.00
1.2
1.4
nmol/l
1.1
1.1
0.01
15
75
(3028308) Erythrocytes [#/volume] in Pleural fluid
43
280
1.55
1.98
1.9
1.4
e6/l
18580.7
72098.0
1.31
29
165
(3000034) Microalbumin [Mass/volume] in Urine
32
195
1.65
1.93
5.4
3.1
mg/l
26.4
36.9
0.23
24
147
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
71
514
1.39
1.93
1.6
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
72
523
1.39
1.92
9.8
6.9
mmol/l
11.7
11.1
0.74
65
464
(3018572) Chloride [Moles/volume] in Blood
72
523
1.39
1.92
9.8
6.9
mmol/l
104.6
105.4
0.59
65
464
(3015235) Bicarbonate [Moles/volume] in Capillary blood
82
609
1.36
1.91
3.8
3.2
mmol/l
23.2
25.1
3.05
70
528
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
600
5456
1.13
1.90
1.7
1.7
mmol/l
1.5
1.3
2.95
537
4500
(3006653) Thiamine [Moles/volume] in Blood
19
99
1.93
1.90
1.4
1.3
nmol/l
128.2
141.1
0.51
19
99
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
16
79
2.03
1.85
1.1
1.0
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
110
858
1.30
1.84
2.4
3.7
u/ml
39.5
61.9
1.10
104
821
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
65
468
1.40
1.84
1.8
1.8
nmol/l
43.9
43.0
0.10
59
442
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
148
1813
0.80
1.82
4.4
4.0
mmol/l
1.2
1.2
0.05
134
1586
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
49
335
1.47
1.82
1.3
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
54
377
1.44
1.81
1.5
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
140
1129
1.26
1.80
5.3
3.6
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
25
146
1.72
1.77
1.1
1.4
—
245.6
—
0
16
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
37
240
1.55
1.76
2.6
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
46
313
1.48
1.76
1.8
1.4
e6/l
1362.8
1605.7
0.42
34
221
(3047181) Lactate [Moles/volume] in Blood
94
723
1.31
1.76
8.5
6.1
mmol/l
1.3
1.3
0.18
83
635
(3044007) Cell count panel - Peritoneal fluid
14
67
2.10
1.76
1.5
2.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
31
193
1.61
1.75
1.8
1.3
nmol/l
1.6
1.5
0.19
31
169
(3012898) Urea [Moles/volume] in Urine
6
18
3.34
1.74
2.0
1.1
mmol/l
152.1
158.9
—
6
13
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
34
217
1.58
1.73
2.7
1.7
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
8
30
2.67
1.72
1.4
1.6
umol/l
44.4
48.0
—
8
30
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
34
218
1.57
1.71
2.6
2.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
37
242
1.54
1.71
2.8
3.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
25
148
1.70
1.70
4.8
2.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
55
760
0.72
1.67
1.8
1.5
—
—
—
0
0
(44806071)
6
19
3.16
1.66
1.2
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
23
134
1.72
1.66
2.5
1.9
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
8
31
2.59
1.66
1.6
2.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
26
157
1.66
1.65
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
39
261
1.50
1.63
1.7
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
150
1.67
1.63
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
167
1391
1.22
1.62
4.1
3.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
23
135
1.71
1.62
1.9
2.1
e6/l
511.9
682.6
—
10
61
(3013005) Retinol [Moles/volume] in Serum or Plasma
12
56
2.15
1.61
1.5
1.5
umol/l
2.4
2.0
0.87
12
49
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
8
32
2.50
1.59
1.6
2.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
54
389
1.40
1.56
1.8
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
114
1.76
1.56
1.1
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
34
224
1.53
1.54
2.7
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
37
249
1.49
1.52
1.1
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
23
138
1.67
1.51
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
17
93
1.83
1.51
1.2
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
27
2.60
1.51
1.0
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
39
266
1.47
1.51
1.1
1.2
u/ml
1.3
3.0
1.08
12
85
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
18
101
1.79
1.49
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
18
101
1.79
1.49
1.1
1.0
—
—
—
0
0
(4015189)
13
65
2.01
1.48
2.8
2.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
67
505
1.34
1.48
1.8
1.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
37
2.44
1.48
1.2
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
111
896
1.25
1.47
1.2
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
24
148
1.63
1.44
1.5
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
69
526
1.32
1.42
1.7
1.6
—
—
—
0
0
(4306422)
36
245
1.48
1.42
1.1
1.2
—
—
—
0
0
(4027681)
16
88
1.82
1.41
1.3
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
11
53
2.08
1.38
1.3
1.3
mu/l
68.6
69.3
0.01
11
40
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
24
150
1.61
1.38
1.1
1.6
u/l
125.6
1754.9
—
6
52
(3017181) Myelocytes/100 leukocytes in Blood
207
1789
1.17
1.37
5.0
4.0
%
1.0
0.9
0.22
72
558
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
17
97
1.76
1.35
1.1
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
68
1.92
1.33
2.1
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
40
284
1.42
1.29
1.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
55
2.00
1.27
1.0
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
20
122
1.64
1.27
1.1
1.3
u/ml
0.0
0.9
—
10
66
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
22
138
1.60
1.26
1.8
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
22
138
1.60
1.26
1.8
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
18
107
1.69
1.25
1.9
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
18
107
1.69
1.25
1.9
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
36
2.23
1.24
1.0
1.1
—
—
—
0
0
(4146454)
36
254
1.42
1.22
2.0
2.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
42
305
1.38
1.21
1.5
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
38
272
1.40
1.19
2.9
1.7
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
58
445
1.31
1.19
1.1
1.2
mmol/l
4.1
3.9
0.64
58
415
(3025130) Human papilloma virus identified in Specimen
19
117
1.63
1.18
1.6
1.8
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
12
64
1.88
1.18
1.4
1.2
%
13.3
24.7
1.74
12
47
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
24
157
1.53
1.17
1.3
1.1
—
5.4
—
0
5
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
21
133
1.58
1.17
2.3
2.1
ug/min
345.8
134.0
—
5
32
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
39
2.05
1.15
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
65
1.85
1.13
1.5
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
30
2.34
1.12
1.4
1.0
—
—
—
0
0
(4198724)
7
30
2.34
1.12
1.4
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
45
336
1.35
1.12
1.5
1.3
u/l
12.6
10.5
0.36
36
267
(3000012) Reticulocyte production index
5
115
0.43
1.11
1.0
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
41
302
1.36
1.11
1.0
1.1
iu/ml
42.8
81.9
—
5
52
(3045788) Cell count panel - Pleural fluid
35
251
1.40
1.10
1.8
1.5
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
25
168
1.49
1.09
1.2
1.1
—
60.6
—
0
14
(3026480) Teichoate Ab [Titer] in Serum
5
21
2.38
1.09
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
120
1.59
1.08
4.0
3.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
32
2.19
1.08
2.3
1.4
ng/l
206.9
127.8
—
7
32
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
32
2.19
1.08
17.6
14.6
mmol/l
4.5
5.5
—
7
32
(3044941) Cell count panel - Synovial fluid
48
365
1.32
1.07
1.5
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
18
113
1.60
1.05
1.1
1.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
40
531
0.75
1.03
5.9
5.0
mmol/l
2.9
2.7
0.18
30
373
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
17
106
1.61
1.02
1.1
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
13
75
1.74
1.02
1.5
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
13
75
1.74
1.02
2.2
2.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
63
501
1.26
1.02
1.2
1.3
mg/l
599.6
549.7
0.24
63
468
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
25
172
1.46
1.00
1.1
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
76
1.71
0.99
1.0
1.0
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
11
61
1.81
0.98
1.3
1.2
ug/l
361.0
134.6
—
6
30
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
23
2.18
0.98
1.2
1.8
umol/l
17.1
17.2
—
5
23
(3035637) Corticotropin [Mass/volume] in Plasma
34
249
1.37
0.97
1.4
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
43
327
1.32
0.97
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
73
595
1.23
0.96
1.5
1.7
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
25
174
1.44
0.95
1.2
1.1
—
64.0
—
0
7
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
19
125
1.52
0.94
2.1
2.1
%
14.5
15.3
—
6
46
(3008898) HLA-B27 [Presence]
59
472
1.26
0.93
1.0
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
9
52
1.73
0.92
1.1
1.2
%
114.8
110.0
—
9
43
(3017704) Immunofixation for Urine
21
142
1.48
0.92
1.1
1.7
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
2.0
1.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
101
1186
0.84
0.91
1.9
1.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
19
126
1.51
0.91
1.5
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
179
1587
1.14
0.91
5.2
4.0
%
0.0
0.3
0.70
54
428
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
86
1.63
0.91
1.1
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
40
306
1.31
0.89
1.2
1.2
miu/ml
96.5
206.6
1.99
13
125
(3039443) Prostate specific Ag panel - Serum or Plasma
30
403
0.74
0.87
2.1
1.7
—
—
—
0
0
(4133840)
8
44
1.82
0.86
1.3
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
120
1.50
0.85
2.7
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
29
213
1.37
0.84
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
56
452
1.24
0.83
1.8
1.7
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
54
434
1.25
0.83
1.3
1.5
e6/l
379.9
779.6
0.56
47
348
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
54
434
1.25
0.83
1.2
1.4
e6/l
5.4
32.4
1.20
46
332
(3012441) Differential panel - Pleural fluid
35
266
1.32
0.82
1.7
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
33
249
1.33
0.82
3.6
3.5
%
54.7
57.1
0.22
26
153
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
6
32
1.88
0.81
1.5
3.4
umol/l
35.0
41.7
—
6
25
(40765096) Chromosome analysis panel by Banding
13
81
1.61
0.81
1.2
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
89
1.58
0.81
2.8
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
89
1.58
0.81
2.8
1.8
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
19
130
1.47
0.80
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
19
130
1.47
0.80
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
19
130
1.47
0.80
1.3
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3036603) Volume of Urine
20
139
1.44
0.79
1.5
1.4
ml
1618.4
1853.5
—
5
26
(3011412) CD3 cells [#/volume] in Blood
24
173
1.39
0.78
2.1
2.1
e9/l
1.3
1.0
0.41
12
100
(3009871) Measles virus Ab [Titer] in Serum
8
48
1.67
0.78
1.7
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
82
1.59
0.78
1.3
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
189
1703
1.12
0.77
5.3
4.0
%
0.1
0.1
0.01
60
520
(3010421) pH of Blood
51
626
0.81
0.76
5.3
4.6
ph
7.4
7.4
0.43
38
525
(3002179) Metamyelocytes/100 leukocytes in Blood
181
1629
1.12
0.75
4.6
3.8
%
0.5
0.6
0.30
51
391
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
53
1.70
0.75
1.7
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
14
91
1.54
0.75
2.8
1.8
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
31
236
1.32
0.74
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
19
133
1.43
0.73
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
19
133
1.43
0.73
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
19
133
1.43
0.73
1.3
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
170
1529
1.12
0.72
2.7
2.2
nmol/l
11.6
12.7
0.93
150
1327
(4268621)
24
176
1.37
0.72
2.1
2.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
27
202
1.34
0.72
1.7
1.4
%
32.9
27.5
0.23
14
123
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
17
117
1.46
0.71
2.6
2.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
34
264
1.29
0.71
1.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
26
1.93
0.70
1.4
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
33
257
1.29
0.68
3.8
4.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
12
77
1.56
0.68
1.3
1.4
umol/l
26.1
21.9
0.16
12
72
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
61
1.64
0.68
2.4
2.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
51
419
1.22
0.68
1.9
1.8
iu/l
5.1
4.5
0.13
15
136
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
59
1.53
0.68
5.2
8.2
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
5
28
1.79
0.66
1.0
1.4
pmol/l
43.3
41.1
—
5
23
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
20
145
1.38
0.65
1.2
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
48
394
1.22
0.65
3.6
3.6
%
0.8
1.5
1.51
41
300
(3036048) Francisella tularensis Ab [Titer] in Serum
7
44
1.59
0.65
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
10
62
1.62
0.65
1.8
1.9
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
21
154
1.37
0.65
2.3
2.1
ug/l
1.9
2.0
0.11
16
129
(3040151) Glucose [Moles/volume] in Capillary blood
33
260
1.27
0.64
1.6
7.0
mmol/l
7.2
7.5
0.13
23
220
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
40
323
1.24
0.63
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
41
333
1.24
0.62
2.7
2.6
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
20
147
1.36
0.61
1.2
1.0
u/ml
4.7
2.0
—
8
43
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
30
1.67
0.61
1.4
1.5
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
50
1.60
0.61
4.9
8.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
53
444
1.20
0.60
1.6
1.3
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
20
0.00
0.60
0.0
1.3
—
0.5
—
0
14
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
38
308
1.24
0.59
1.4
1.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
53
1.51
0.58
1.6
2.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
23
0.00
0.58
0.0
4.7
—
—
—
0
0
(3001729) Color of Synovial fluid
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(4094501)
67
576
1.17
0.58
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
26
202
1.29
0.57
1.4
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
54
1.48
0.57
2.6
2.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
55
1.46
0.56
1.3
1.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
25
194
1.29
0.56
1.1
1.1
u/ml
4.2
1.2
0.36
13
77
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
33
406
0.81
0.55
4.0
3.5
%
59.1
58.2
0.19
33
406
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
50
422
1.19
0.54
1.2
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
29
231
1.26
0.54
1.3
1.3
mosm/kgh2o
278.5
275.7
0.20
19
171
(4024509)
27
214
1.26
0.52
1.4
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
16
117
1.37
0.52
2.6
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
16
117
1.37
0.52
2.6
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
16
117
1.37
0.52
2.6
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
16
117
1.37
0.52
2.6
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
32
391
0.82
0.51
3.7
3.3
e9/l
4.3
4.3
0.01
32
391
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
268
0.78
0.49
1.1
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
11
77
1.43
0.45
1.7
2.9
umol/l
120.1
96.4
—
5
49
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
19
147
1.29
0.45
1.1
1.2
mmol/l
2.1
2.1
0.01
19
137
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
43
367
1.17
0.44
3.8
3.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
46
395
1.17
0.44
1.2
1.4
—
—
—
0
0
(4281824)
25
202
1.24
0.43
1.1
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
14
104
1.35
0.43
7.0
5.9
u/ml
155.8
62.4
—
5
26
(3037556) Urate [Mass/volume] in Serum or Plasma
11
78
1.41
0.43
1.0
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
57
499
1.15
0.43
2.6
2.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
56
1.43
0.42
2.5
1.3
ug/l
9.0
8.9
—
8
56
(40757373) Influenza virus identified in Isolate
8
56
1.43
0.42
2.0
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
25
203
1.23
0.42
1.2
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
21
167
1.26
0.41
1.0
1.1
u/ml
0.9
1.6
0.37
11
65
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
51
445
1.15
0.40
1.2
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
17
0.00
0.40
0.0
5.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
60
1.33
0.40
1.5
2.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
35
1.43
0.39
2.2
1.4
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.9
—
1.1
—
0
13
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
37
1.35
0.37
5.6
8.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
18
222
0.81
0.34
1.1
1.3
mmol/l
7.4
7.6
0.04
13
163
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
44
1.36
0.34
1.3
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
46
1.31
0.33
1.0
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
23
192
1.20
0.32
3.0
2.2
ml
841.9
636.0
1.26
16
118
(3047007) Chlamydophila sp Ab [Presence] in Serum
26
220
1.18
0.31
1.2
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
15
119
1.26
0.31
1.1
1.1
u/ml
1.9
3.1
—
9
53
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
13
101
1.29
0.31
1.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
14
110
1.27
0.31
1.4
2.5
mmol/l
9.1
9.3
—
8
90
(3042111) Morphology [Interpretation] in Bone marrow Narrative
48
427
1.13
0.31
1.4
1.5
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
7
52
1.35
0.31
1.7
2.2
%
7.7
7.8
—
7
45
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(44806420)
10
75
1.33
0.30
2.2
2.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
24
203
1.18
0.30
1.2
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
62
1.29
0.28
1.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
62
1.29
0.28
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
67
1.19
0.26
1.0
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
223
2326
0.95
0.26
3.6
3.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
86
1.28
0.26
1.7
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
203
0.84
0.25
1.3
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
169
1.18
0.25
2.1
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
72
1.25
0.25
1.3
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
74
1.22
0.25
11.1
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
74
1.22
0.25
11.1
2.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
74
1.22
0.25
1.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
14
114
1.23
0.25
1.7
2.6
—
—
—
0
0
(44813793)
13
105
1.24
0.24
1.4
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
82
0.73
0.24
1.2
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
84
0.71
0.24
1.5
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
12
147
0.82
0.23
1.0
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
171
1.17
0.23
1.1
1.0
u/ml
3.2
3.6
0.05
13
73
(3045142) Bone marrow Pathology biopsy report
30
267
1.13
0.21
1.3
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
42
1.19
0.21
1.2
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
42
1.19
0.21
1.0
3.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
43
1.16
0.21
1.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
43
1.16
0.21
1.2
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.2
—
101.3
—
0
13
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
117
1.20
0.20
1.1
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
117
1.20
0.20
1.1
1.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
48
1.25
0.20
1.2
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
48
1.25
0.20
1.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
48
1.25
0.20
2.2
1.5
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
6
51
1.18
0.19
1.7
2.2
%
26.3
30.2
—
6
46
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
60
1.17
0.17
1.3
3.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
60
1.17
0.17
1.1
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
16
138
1.16
0.17
2.1
2.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
157
1.15
0.17
1.2
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
67
0.75
0.17
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
68
0.73
0.17
1.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
56
524
1.07
0.16
5.2
4.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
183
0.87
0.16
1.1
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
92
1.20
0.16
1.5
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
151
0.86
0.15
1.2
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
78
0.77
0.15
1.3
1.2
iu/ml
232.0
214.7
—
6
78
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
9
83
1.08
0.14
1.0
1.2
—
74.2
—
0
12
(3004451) EKG impression Narrative
14
122
1.15
0.13
1.1
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
60
568
1.06
0.13
1.9
1.7
mg/l
2.1
3.9
0.94
48
417
(40768800) Prostate Pathology biopsy report
61
578
1.06
0.13
1.3
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
16
142
1.13
0.12
1.3
1.5
umol/l
15.0
14.1
0.19
16
134
(3047189) Immunofixation for 24 hour Urine
14
124
1.13
0.11
1.5
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
14
124
1.13
0.11
2.5
3.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
44
416
1.06
0.11
1.3
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
115
0.87
0.10
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
249
0.92
0.10
1.4
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
17
187
0.91
0.10
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
44
1.14
0.10
1.0
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
114
0.88
0.09
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
47
1.06
0.09
1.4
2.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
17
186
0.91
0.09
1.1
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
14
155
0.90
0.09
4.2
4.9
u/ml
28.2
49.9
—
8
39
(3029075) Extractable nuclear Ab panel - Serum
6
55
1.09
0.09
1.0
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
15
136
1.10
0.08
3.5
2.0
min
529.7
487.1
1.34
15
95
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
12
107
1.12
0.08
1.4
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
67
1.04
0.08
1.6
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
127
1.10
0.08
1.1
1.0
u/ml
0.4
2.8
—
7
54
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
108
1.11
0.07
1.3
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
88
1.02
0.07
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
226
1.06
0.06
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
53
512
1.04
0.06
3.7
2.5
%
16.4
16.0
0.29
37
259
(3023323) Follitropin [Units/volume] in Serum or Plasma
38
366
1.04
0.05
1.4
1.3
iu/l
37.3
34.5
0.16
33
307
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
110
0.91
0.05
5.3
6.1
—
—
—
0
0
(1002224) Polysomnography panel
65
634
1.03
0.05
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
503
5060
0.99
0.04
4.5
3.6
—
—
—
0
0
(4034850)
66
673
0.98
0.03
13.5
10.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
159
0.94
0.03
1.3
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
25
258
0.97
0.02
1.3
1.1
—
12.5
—
0
10
(3044242) Glucose [Moles/volume] in Arterial blood
12
127
0.94
0.01
1.6
2.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
114
1.05
0.00
4.5
3.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
134
0.97
0.00
1.1
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
134
0.97
0.00
1.1
1.5
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
14
138
1.01
0.00
1.1
1.1
nmol/l
0.2
4.9
—
7
29
(3006442) Creatine [Moles/volume] in Serum or Plasma
14
138
1.01
0.00
2.4
1.6
—
71.6
—
0
9
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
92
0.98
0.00
1.3
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
56
0.89
0.00
4.6
2.4
nmol/l
317.4
138.2
—
5
49
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
85
0.94
0.00
4.8
1.7
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
55
0.91
0.00
1.2
1.1
miu/ml
1376.2
1636.5
—
5
55
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
1.3
—
0
6
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
10.2
—
0
5
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
3776.0
—
0
5
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
1.6
—
0
5
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
6
0.00
0.00
0.0
9.3
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_DESCENDING_COLON and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_DESCENDING_COLON | 1.226 [1.09, 1.38] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.251 |
During the follow-up period (1.1.1998 — 31.12.2019), 872 out of 4109 females with CD2_BENIGN_DESCENDING_COLON died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_DESCENDING_COLON | 1.327 [1.18, 1.5] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1413 out of 5120 males with CD2_BENIGN_DESCENDING_COLON died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_DESCENDING_COLON.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.109% | 0.179% |
| 5 | 0.695% | 1.384% |
| 10 | 2.046% | 3.572% |
| 15 | 3.64% | 6.784% |
| 20 | 6.548% | 11.258% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_DESCENDING_COLON – Benign neoplasm: Descending colon
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data